Literature DB >> 16440160

Effect of prostaglandin E1 on ischemia-reperfusion injury during abdominal aortic aneurysm surgery.

Hidenori Sako1, Tetsuo Hadama, Shinji Miyamoto, Hirofumi Anai, Tomoyuki Wada, Eriko Iwata, Hirotsugu Hamamoto, Hideyuki Tanaka, Keiko Urushino, Takashi Shuto.   

Abstract

OBJECTIVE: Abdominal aortic aneurysm (AAA) surgery subjects the lower extremities to ischemia and reperfusion. Although it is not extensive or prolonged, ischemia of the lower extremities during aortic cross-clamping is gradually and steadily induced. We studied the effects of prostaglandin E1 (PGE1) on ischemia-reperfusion injury of the lower extremities during AAA repair.
METHODS: During AAA surgery, two near-infrared spectroscopy probes were positioned on each calf muscle to monitor oxygen metabolism in the lower extremities. We also measured lactate concentration in both iliac veins.
RESULTS: Near-infrared spectroscopy signals responded sensitively to aortic cross-clamping and declamping. Lactate increased time-dependently during aortic cross-clamping. The continuous venous administration of PGE1 (20 ng/kg per minute) inhibited the accumulation of lactate during aortic cross-clamping. Declamping of the first iliac artery resulted in a further but transient increase in ipsilateral venous lactate, which may be one component in the mechanism of declamping shock. Prostaglandin E1 eliminated the transient increase in ipsilateral lactate. The administration of PGE1 inhibited the contralateral accumulation of lactate after first declamping, and the lactate level decreased gradually before the second declamping.
CONCLUSIONS: Prostaglandin E1 seems to have a protective effect against ischemia-reperfusion injury of the lower extremities during AAA surgery.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16440160     DOI: 10.1007/s00595-005-3116-2

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  14 in total

1.  Noninvasive measurement of cerebral hemoglobin oxygen saturation using two near infrared spectroscopy approaches.

Authors:  V Quaresima; S Sacco; R Totaro; M Ferrari
Journal:  J Biomed Opt       Date:  2000-04       Impact factor: 3.170

2.  Regional tissue metabolism during open or endovascular abdominal aortic aneurysm surgery.

Authors:  C Metzsch; J Lundberg; L Norgren
Journal:  Eur J Vasc Endovasc Surg       Date:  2001-04       Impact factor: 7.069

3.  Prostaglandin E1 reduces ischemia/reperfusion injury by normalizing nitric oxide and superoxide release.

Authors:  I Huk; V Brovkovych; J Nanobashvili; C Neumayer; P Polterauer; M Prager; S Patton; T Malinski
Journal:  Shock       Date:  2000-08       Impact factor: 3.454

4.  Prevention of contrast media-induced renal dysfunction with prostaglandin E1: a randomized, double-blind, placebo-controlled study.

Authors:  M H Sketch; A Whelton; E Schollmayer; J A Koch; P J Bernink; F Woltering; J Brinker
Journal:  Am J Ther       Date:  2001 May-Jun       Impact factor: 2.688

5.  Vitamin E protects human skeletal muscle from damage during surgical ischemia-reperfusion.

Authors:  G P Novelli; C Adembri; E Gandini; S Z Orlandini; L Papucci; L Formigli; L I Manneschi; A Quattrone; C Pratesi; S Capaccioli
Journal:  Am J Surg       Date:  1997-03       Impact factor: 2.565

6.  Prostaglandin E1 protects lung transplants from ischemia-reperfusion injury: a shift from pro- to anti-inflammatory cytokines.

Authors:  M de Perrot; S Fischer; M Liu; R Jin; X H Bai; T K Waddell; S Keshavjee
Journal:  Transplantation       Date:  2001-11-15       Impact factor: 4.939

7.  Effects of PGE-1 in patients suffering from peripheral arterial occlusive disease.

Authors:  G Milio; V Cospite; M Cospite
Journal:  Minerva Cardioangiol       Date:  2003-06       Impact factor: 1.347

8.  Influence of prostaglandin E1 on tissue ischemia during surgical repair of the abdominal aorta.

Authors:  A Gabriel; A Werba; P Mares; G Grubhofer; F Hrska; A Griesmacher; G Kretschmer; F X Lackner; N G Bircher; S Schwarz
Journal:  J Cardiothorac Vasc Anesth       Date:  1996-02       Impact factor: 2.628

9.  Reduction of canine infarct size by bolus intravenous administration of liposomal prostaglandin E1: comparison with control, placebo liposomes, and continuous intravenous infusion of prostaglandin E1.

Authors:  S Feld; G Li; A Wu; P Felli; J Amirian; W K Vaughn; T Gornet; C Swenson; R W Smalling
Journal:  Am Heart J       Date:  1996-10       Impact factor: 4.749

10.  A multiantioxidant supplementation reduces damage from ischaemia reperfusion in patients after lower torso ischaemia. A randomised trial.

Authors:  M H W A Wijnen; R M H Roumen; H L Vader; R J A Goris
Journal:  Eur J Vasc Endovasc Surg       Date:  2002-06       Impact factor: 7.069

View more
  3 in total

1.  Beneficial effects of intra-arterial and intravenous prostaglandin E1 in intestinal ischaemia-reperfusion injury.

Authors:  Enrique María San Norberto García; James Henry Taylor; Noelia Cenizo; Carlos Vaquero
Journal:  Interact Cardiovasc Thorac Surg       Date:  2014-01-14

2.  Effects of prostaglandin E1 on reperfusion injury patients: A meta-analysis of randomized controlled trials.

Authors:  Houyong Zhu; Xiaoqun Xu; Yu Ding; Liang Zhou; Jinyu Huang
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

3.  Near infrared spectroscopy (NIRS) of the thenar eminence in anesthesia and intensive care.

Authors:  Miklos Lipcsey; Nicholas Cz Woinarski; Rinaldo Bellomo
Journal:  Ann Intensive Care       Date:  2012-05-08       Impact factor: 6.925

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.